EP0000984A1 - Stimulateur programmable avec amplificateur a gain variable - Google Patents

Stimulateur programmable avec amplificateur a gain variable Download PDF

Info

Publication number
EP0000984A1
EP0000984A1 EP78300237A EP78300237A EP0000984A1 EP 0000984 A1 EP0000984 A1 EP 0000984A1 EP 78300237 A EP78300237 A EP 78300237A EP 78300237 A EP78300237 A EP 78300237A EP 0000984 A1 EP0000984 A1 EP 0000984A1
Authority
EP
European Patent Office
Prior art keywords
pacer
amplifier
signals
output
input amplifier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP78300237A
Other languages
German (de)
English (en)
Other versions
EP0000984B1 (fr
Inventor
John Walter Keller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotronik SE and Co KG
Original Assignee
Biotronik Mess und Therapiegeraete GmbH and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/917,142 external-priority patent/US4202342A/en
Application filed by Biotronik Mess und Therapiegeraete GmbH and Co filed Critical Biotronik Mess und Therapiegeraete GmbH and Co
Publication of EP0000984A1 publication Critical patent/EP0000984A1/fr
Application granted granted Critical
Publication of EP0000984B1 publication Critical patent/EP0000984B1/fr
Expired legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/37211—Means for communicating with stimulators

Definitions

  • This invention relates to implantable body function control apparatus and particularly, but not exclusively, to body tissue stimulating devices such as cardiac pacemakers.
  • Pacemakers for generating artificial stimulating pulses for the heart, and which may be implanted in the body, are well known.
  • the electrical circuitry for such pacemakers was of analog design, but in recent years digital circuitry has been also employed.
  • a digital approach to pacemakers has led to the evolution of programmable pacemakers --pacemakers having parameters such as pulse rates which are adjustable (programmable) once the pacemaker has been implanted.
  • the programs can be changed from outside the patient's body by appropriate signal transmission to the implanted pacemaker and without surgery.
  • Programmable pacemakers are described in, for instance, British Specifications 1,385,954 and 1,398,875.
  • Such pacemakers have circuitry to detect and decode signals transmitted outside the body and alter the program accordingly.
  • pacemakers are of the demand type - that is they only'supply a stimulating pulse to the heart when a natural heart beat is absent. To accomplish this, demand pacemakers have means for sensing the presence or absence of natural heart beats and for actuating the stimulating pulse as appropriate.
  • Demand pacemakers normally have an input amplifier which receives the electrical signals detected at the heart, and the amplified signals are then employed to control the demand function of the pacemaker.
  • signals provided by the input amplifier are employed to inhibit any artificial pulse being generated by the pacemaker: the absence of such signals being taken by the pacemaker as indicating the absence of a normal heart beat and causing artificial stimulating pulses to be generated.
  • Pacemakers are implanted in the body for a period of years, and during that time various parameters can change causing the effective signals supplied by the input amplifier to change in magnitude. Typical of such parameters is an increase in impedance of the body tissue as "seen" by the pacing electrode. But most prevalent is the wide range of electrode placement effectiveness which can result in not only very large but very small signals.
  • an implantable, body tissue stimulating apparatus comprising means for providing electrical signals for artificially stimulating body tissue in relation to sensed signals, said providing means including an input amplifier for receiving input signals from the body and for providing output signals for controlling the operation of the apparatus, means, for controlling the magnitude of the output signals provided by the input amplifier, a program store for holding a program which controls said magnitude controlling means, and means for changing the program stored by the program store.
  • the magnitude control means can take several forms, but preferably includes a potential dividing network which by means of switching resistors into and out of the network, can be employed to control the signal levels at the input amplifier, This can be accomplished either on the input side of the amplifier (the input signals being supplied to the network before passing to the amplifier), by including the network in an amplifier feed-back loop (enabling the amplifier gain to be varied), or on the output side of the amplifier. Of these three alternatives, the first is preferred.
  • the pacemaker comprises an oscillator 1 which clocks a ripple counter 2.
  • Various outputs from the ripple counter are combined as is known in the art by means of logic gates (not shown) to provide four output lines 3.
  • the oscillator frequency and combination of ripple counter outputs are selected so that the four output lines 3 provide, respectively, body stimulation pulses at four different frequencies (e.g. 50,-60, 70, 80 pulses per minutel.
  • the four output lines 3 are supplied to a rate decoder 4 provided with two input control lines 5.
  • the logic levels on lines 5 can be employed to select uniquely one from four of the four lines 3 and transmit the selected pulse frequency on line 6.
  • Line 6 is connected to an output amplifier 7 which in turn is connected to a connection 8 which leads to an active stimulating pulse electrode (not shown) disposed in or on the heart.
  • Line 6 also provides one input to an OR gate 9.
  • OR gate 9 The output of OR gate 9 is supplied to a delay unit 10 whose output is employed to reset counter 2, The delay generated by delay unit 10 sets the pulse width for each artificial stimulating pulse which is transmitted on output line 6.
  • the active electrode disposed in or on the heart feeds back the electrical signals detected at the heart (arising from an artificial stimulating pulse or a natural heart beat) to the pacemaker via a resistor 11' (R 1 ).
  • the output of resistor R 1 is connected to an input amplifier 12 which in turn supplies a second input to OR gate 9.
  • the feedback loop for such signals through the active electrode is illustrated by means of line 13.
  • a second resistor 14 Connected to input amplifier 12 is a second resistor 14 (R 2 ), which is connected via a capacitor 15 to the drain of a field effect transistor 16, the source of which is connected to V DD .
  • the gate of the transistor 16 is controlled by a control line 17 which, as with control lines 5, extends from a pacemaker program store 18.
  • the program store 18 is arranged to hold, as a pacemaker program, a series of binary values for supply on the control lines 5 and 17.
  • a receiver/decoder 19 is arranged to receive and decode data signals transmitted from outside the patient's body to the implanted pacemaker, and to employ the decoded signals for changing a pacemaker program held in program store 18.
  • the data signals may be transmitted to the receiver/decoder 19 by any suitable means, but preferably we employ data signals transmitted by tone burst modulation (pulse width modulation of a carrier frequency).
  • tone burst modulation pulse width modulation of a carrier frequency
  • the pacemaker operates as follows. A program is entered and held in the program store 18 and the binary levels on control lines 5 determine which one of the four outputs 3 derived from counter 2 is passed by rate decoder 4 onto output line 6.
  • the counter 2 In the absence of natural heart beats, .the counter 2 successively generates a series of artificial pulses at the selected rate and these are supplied to the heart via output amplifier 7. Each artificial pulse causes a reset of counter 2 via OR gate 9 and delay 10 to enable the count for the next artificial pulse to commence.
  • the pacemaker operates in a normal demand mode - issuing artificial pulses only when demanded by the heart. It is of no consequence if the reset initiated by a natural heart beat arrives just as an artificial pulse is generated, since the natural beat and the stimulating pulse will essentially coincide.
  • a "0" is held in the program store 18 and this causes attenuation of the input signal to amplifier 12.
  • the gain of amplifier 12 and other parameters of the circuit are set such that this attenuation is acceptable and that the attenuated signal received is still of sufficient magnitude to carry out its necessary function of controlling the demand function of the pacemaker.
  • the program is changed to "1", to cause R 2 to float and remove attenuation of the input signal.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Electrotherapy Devices (AREA)
EP19780300237 1977-08-19 1978-08-03 Stimulateur programmable avec amplificateur a gain variable Expired EP0000984B1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB3491777 1977-08-19
GB3491777 1977-08-19
US917142 1978-06-19
US05/917,142 US4202342A (en) 1977-08-19 1978-06-19 Programmable pacer with variable amplifier sensitivity and pacing rate

Publications (2)

Publication Number Publication Date
EP0000984A1 true EP0000984A1 (fr) 1979-03-07
EP0000984B1 EP0000984B1 (fr) 1983-05-11

Family

ID=26262494

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19780300237 Expired EP0000984B1 (fr) 1977-08-19 1978-08-03 Stimulateur programmable avec amplificateur a gain variable

Country Status (4)

Country Link
EP (1) EP0000984B1 (fr)
AU (1) AU3895778A (fr)
CA (1) CA1098591A (fr)
DE (1) DE2862246D1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440199A1 (fr) * 1978-11-06 1980-05-30 Medtronic Inc Stimulateur cardiaque a la demande
EP0491907A1 (fr) * 1990-07-06 1992-07-01 Medtronic Inc Procede et appareil permettant d'acceder a une memoire remanente.
US11944526B2 (en) 2013-09-19 2024-04-02 The Procter & Gamble Company Absorbent cores having material free areas

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830242A (en) * 1970-06-18 1974-08-20 Medtronic Inc Rate controller and checker for a cardiac pacer pulse generator means
LU76880A1 (fr) * 1976-03-03 1977-07-12

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3830242A (en) * 1970-06-18 1974-08-20 Medtronic Inc Rate controller and checker for a cardiac pacer pulse generator means
LU76880A1 (fr) * 1976-03-03 1977-07-12

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ELECTRONICS, vol. 48, nr. 14, July 10, 1975, New York. C.J. HARTLEY: "Digital word sets gain of amplifier", pages 94,95 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440199A1 (fr) * 1978-11-06 1980-05-30 Medtronic Inc Stimulateur cardiaque a la demande
EP0011932A2 (fr) * 1978-11-06 1980-06-11 Medtronic, Inc. Stimulateur cardiaque
EP0011932A3 (fr) * 1978-11-06 1981-01-07 Medtronic, Inc. Stimulateur cardiaque
EP0491907A1 (fr) * 1990-07-06 1992-07-01 Medtronic Inc Procede et appareil permettant d'acceder a une memoire remanente.
EP0491907A4 (en) * 1990-07-06 1993-02-24 Medtronic, Inc. Method and apparatus for accessing a nonvolatile memory
US11944526B2 (en) 2013-09-19 2024-04-02 The Procter & Gamble Company Absorbent cores having material free areas

Also Published As

Publication number Publication date
EP0000984B1 (fr) 1983-05-11
AU3895778A (en) 1980-02-21
CA1098591A (fr) 1981-03-31
DE2862246D1 (en) 1983-06-16

Similar Documents

Publication Publication Date Title
US5443486A (en) Method and apparatus to limit control of parameters of electrical tissue stimulators
US4556063A (en) Telemetry system for a medical device
US4606349A (en) Implantable cardiac pacer having dual frequency programming and bipolar/unipolar lead programmability
US5016634A (en) Implantable medical device with means for telemetric transmission of data
US4181133A (en) Programmable tachycardia pacer
US4066086A (en) Programmable body stimulator
USRE32361E (en) Implantable telemetry transmission system for analog and digital data
DE68922362T2 (de) Körperleitungspfad in einem Kommunikationssystem einer medizinischen Vorrichtung.
US4561444A (en) Implantable cardiac pacer having dual frequency programming and bipolar/linipolar lead programmability
US5243979A (en) Method and apparatus for implementing activity sensing in a pulse generator
EP0349130B1 (fr) Stimulateur cardiaque implantable avec commande du gain automatique
US4024875A (en) Device for non-invasive programming of implanted body stimulators
EP0559193B1 (fr) Stimulateur cardiaque implantable produisant une hysterésis en fonctionnement double chambre
ES456504A1 (es) Un marcapasos cardiaco numerico implantable mejorado.
GB2079610A (en) Body-implantable electromedical apparatus
US4665919A (en) Pacemaker with switchable circuits and method of operation of same
GB1398875A (en) Implantable electromedical apparatus
SE451670B (sv) Hjertstimulator med formaksstyrd funktion
US4757816A (en) Telemetry system for implantable pacer
US4202342A (en) Programmable pacer with variable amplifier sensitivity and pacing rate
EP0000984A1 (fr) Stimulateur programmable avec amplificateur a gain variable
US4203448A (en) Programmably variable voltage multiplier for implanted stimulator
CA1183576A (fr) Systeme de telemetrie pour dispositif medical
EP0879619B1 (fr) Stimulateur cardiaque avec réponse de fréquence asservie à une fonction speciale
GB1599231A (en) Body tissue stimulating electro-medical device

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): DE FR GB NL SE

17P Request for examination filed
GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Designated state(s): DE FR GB NL SE

REF Corresponds to:

Ref document number: 2862246

Country of ref document: DE

Date of ref document: 19830616

ET Fr: translation filed
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 19830731

Year of fee payment: 6

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Effective date: 19840804

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 19840828

Year of fee payment: 7

GBPC Gb: european patent ceased through non-payment of renewal fee
PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 19860831

Year of fee payment: 9

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Effective date: 19880301

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 19880429

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Effective date: 19881117

EUG Se: european patent has lapsed

Ref document number: 78300237.1

Effective date: 19850612

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 19971028

Year of fee payment: 20